30 September 2024 - interim results
The medical technology group has announced its interim results for the six months to 30 June with revenues for the period rising by 9.3% to £6.2m with an adjusted pre-tax loss of £0.1m being reported. The company benefited from increased gross margins over the second half of last year and it was pleasing to see the company's SI branded products seeing growth across all key markets. Net debt at the end of the period was £0.5m as opposed to net cash of £0.4m at 1 January 2024 but . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
